Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

PROSTATE CANCER

Genetic ancestry and racial differences in prostate tumours

A striking disproportionate burden of prostate cancer incidence and mortality exists between men of West African ancestry and men of European ancestry. Identifying distinct tumour genetic biomarkers and immunomodulating signals in patients with diverse genetic ancestry might reduce the disparities in prostate cancer prognosis, treatment outcomes and mortality in high-risk racial groups.

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Badal, S. et al. Disparities in prostate cancer incidence and mortality rates: solvable or not? Prostate 80, 3–16 (2020).

    Article  Google Scholar 

  2. Batai, K., Hooker, S. & Kittles, R. A. Leveraging genetic ancestry to study health disparities. Am. J. Phys. Anthropol. 175, 363–375 (2021).

    Article  Google Scholar 

  3. Liu, W. et al. A CD24-p53 axis contributes to African American prostate cancer disparities. Prostate 80, 609–618 (2020).

    CAS  Article  Google Scholar 

  4. Yamoah, K. et al. Prostate tumors of native men from West Africa show biologically distinct pathways—a comparative genomic study. Prostate 81, 1402–1410 (2021).

    CAS  Article  Google Scholar 

  5. Koga, Y. et al. Genomic profiling of prostate cancers from men with African and European ancestry. Clin. Cancer. Res. 26, 4651–4660 (2020).

    CAS  Article  Google Scholar 

  6. Graff, R. E. et al. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer. Prostate 75, 897–906 (2015).

    CAS  Article  Google Scholar 

  7. Semaan, L., Mander, N., Cher, M. L. & Chinni, S. R. TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model. BMC Cancer 19, 972 (2019).

    Article  Google Scholar 

  8. Jamaspishvili, T. et al. Clinical implications of PTEN loss in prostate cancer. Nat. Rev. Urol. 15, 222–234 (2018).

    CAS  Article  Google Scholar 

  9. Nagle, R. B. et al. ERG overexpression and PTEN status predict capsular penetration in prostate carcinoma. Prostate 73, 1233–1240 (2013).

    CAS  Article  Google Scholar 

  10. Sartor, O. et al. Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry. Prostate Cancer Prostatic Dis. 23, 517–526 (2020).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rick A. Kittles.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Johnson, J.R., Kittles, R.A. Genetic ancestry and racial differences in prostate tumours. Nat Rev Urol 19, 133–134 (2022). https://doi.org/10.1038/s41585-021-00544-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41585-021-00544-3

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing